Drug Analysis
THE PROBLEM"Drug manufacturers lacked clear visibility into patient consumption, compound quantity needs, and treatment feedback for chronic conditions like epilepsy, making production, research, and demand planning disconnected from real usage patterns."
SOLUTION OUTCOME80% Clearer Forecasts
DEMAND VISIBILITY
Manufacturing units gained reliable demand visibility from actual consumption data.
35% Waste Cut
UNUSED DRUG COSTS
Companies reduced spend by identifying unused and underperforming drug patterns.
Stronger Trust
PROVIDER CREDIBILITY
Brand credibility improved through consistent drug availability and performance visibility.
Challenges holding Drug Analysis back
Pharma teams struggled to track drug consumption, patient behavior, disease progression, and demand patterns accurately across the treatment lifecycle.
The Challenges
01Consumption Data Gap
Patient consumption patterns and treatment feedback were not consolidated, limiting research visibility into drug formulations and compound usage.
02Demand Forecasting Failure
Manufacturing units lacked visibility into consumption trends, making accurate demand forecasting and production planning difficult.
03Unused Drug Accumulation
Companies continued producing underperforming drug compounds without visibility into unused or low demand variants.
Challenges Impact
Demand
FORECASTING GAP
Drug Waste
SPEND RISK
Research
VISIBILITY GAP
Revenue Lost to Unsold Inventory — Drugs produced without demand visibility remained unused, increasing write offs and reducing margins.
Undetected Side Effects in Production — Untracked side effect and compound progression patterns weakened future formulation decisions
Provider Trust at Risk — Inconsistent drug availability and unresolved efficacy issues reduced provider confidence and prescription share.
Research Cycles Running Blind — Research teams lacked patient consumption feedback to validate real world compound behavior.
Supply Chain Misalignment — Demand supply gaps forced reactive production changes, increasing operational cost and delays.
Data Analytics Reporting Platform to Turn Patient Consumption Data Into Demand-Driven Manufacturing Decisions
A data analytics reporting platform built on a high volume data pipeline and structured data lake, giving manufacturing and research teams the consumption metrics, demand forecasts, and drug performance visibility needed for data driven production decisions across epilepsy stages, drug variants, and demographics.
Solution
Gave manufacturing units clear demand forecasts from actual patient consumption data.
Provided research teams with patient comparison reports to identify compound performance patterns.
Helped commercial teams track unused drug volumes and reduce spend on non performing products.
Enabled population and demographic level drug analysis to support better prescribing decisions.
Solution Highlights
High-Volume Data Pipeline
Processed millions of patient records through an automated transformation pipeline with clean structured analytics data.
Disease Stage Mapping
Mapped epilepsy stages with corresponding drug variants and measured impacts for structured research visibility.
Patient Similarity Reports
Generated comparison reports for patients with similar profiles and treatment histories to identify drug patterns.
Demographic Drug Analysis
Delivered population and geography level analysis of drug consumption and efficacy patterns.
Demand Forecast Visibility
Provided structured dashboards with future demand estimates and production forecast visibility.
Unused Drug Pattern Detection
Identified underperforming and unused drug variants to reduce waste and optimize production spend.
Tech Stack
Azure
Power BI
Functions
Data Lake
Blob Storage
Snowflake
OUTCOMES & FEATURESImproving drug consumption visibility, demand forecasting, and research intelligence
The platform helped pharma teams move from limited drug visibility to a structured analytics environment with better demand forecasting, unused drug detection, patient pattern analysis, and production planning support.
Key Outcomes
80% Better Demand Forecasting
Manufacturing units shifted to data driven production planning based on actual patient consumption.
35% Reduced Inventory Waste
Unused and underperforming drug variants were identified early to reduce overproduction and waste.
Improved Research Quality
Research teams accessed structured patient comparison data grounded in real world consumption patterns.
Side Effect Visibility
Side effect and compound progression patterns became trackable across patient populations.
Stronger Provider Relationships
Consistent drug availability and efficacy reporting improved provider trust.
Scalable Analytics Foundation
The analytics platform scaled across growing data volumes, drug lines, and geographies.
Features
Drug Consumption Analytics
Demand Forecasting
Epilepsy Stage Analysis
Drug Variant Mapping
Patient Similarity Reports
Disease Progression Insights
Unused Drug Pattern Detection
Our Engineering
Marvels
That Drive
Digital Transformation
Discover how our technology solutions helped businesses improve operations, automate workflows, and achieve measurable outcomes.
Insurance Operator
Claims friction, verification delays, and payer-clinic coordination gaps made it difficult for plan holders to use medical benefits smoothly within the registered clinic network.
Regimen Tracker
Oncology teams struggled with disconnected regimen tracking, unbalanced workloads, delayed lab coordination, and long patient wait times across the treatment journey.
Emergency Assistance
Patients struggled to access timely emergency support, while providers and payers lacked visibility into active incidents, care coordination, and response tracking.
Payer Insights
Healthcare payers struggled to consolidate claims, referral, utilization, and network data, limiting visibility into plan performance, risk, and network leakage.
Health SignOn
The company struggled to manage application access, user roles, data processing, and language requirements consistently across multiple geographies without increasing manual effort or data errors.
